SERMORELIN 5mg

GHRH (1-29)

Sermorelin (GRF 1-29) is a specialized research peptide utilized primarily to investigate the stimulation of endogenous growth hormone secretion and the regulation of the hypothalamic-pituitary-somatotropic axis. As a synthetic 29-amino acid analog of the naturally occurring growth hormone-releasing hormone (GHRH), it represents the shortest fully functional fragment of the native hormone. Dragon Pharma provides Sermorelin 5mg at a purity level of 99%+, specifically for use in in-vitro laboratory experiments and preclinical animal models.

Overview

In the realm of neuroendocrinology and metabolic research, Sermorelin (Growth Hormone Releasing Factor 1-29) has become a fundamental tool for investigators exploring the biological regulation of growth and cellular repair. This compound is the functional acetate salt of an amidated synthetic peptide that corresponds to the amino-terminal segment of the naturally occurring 44-amino acid human GHRH. Dragon Pharma provides Sermorelin 5mg at a minimum purity of 99%, ensuring that researchers have access to a high-grade Research Peptide capable of producing reproducible and accurate data in complex biological models.

As scientific inquiry into pituitary function, sarcopenia, and sleep-cycle modulation expands, the need for reliable GHRH agonists like Sermorelin has grown. This expanded profile examines the biochemical characteristics, structural integrity, and multifaceted research applications of Sermorelin 5mg.

Molecular Characteristics and Chemical Profile

The structural integrity of Sermorelin allows it to bind specifically to GHRH receptors in the anterior pituitary. Its 29-amino acid sequence contains the full biological activity required to stimulate somatotroph cells, making it a highly efficient model for studying endocrine signaling.

• Chemical Identity: Sermorelin Acetate (GRF 1-29)
• Molecular Formula: C149H246N44O42S
• Molecular Weight: 3357.9 g/mol
• Purity: >99% (HPLC and Mass Spectrometry verified)
• Form: Lyophilized powder
• Manufacturer: Dragon Pharma

Research Applications

The peptide is utilized in various scientific investigative domains, including:

• Somatotropic Signaling: Mapping the pathways of pulsatile growth hormone secretion.
• Pituitary Reserve: Investigating the secretory capacity of the anterior pituitary gland.
• Metabolic Homeostasis: Studying the modulation of body composition and lipid metabolism.
• Sleep Physiology: Researching the link between GHRH signaling and Delta-wave (deep) sleep.
• Tissue Repair: Assessing the downstream impact of the IGF-1 axis on wound healing and musculoskeletal recovery.

Pathway and Mechanistic Context

The core value of Sermorelin 5mg in a laboratory setting is its ability to manipulate the growth hormone axis through natural feedback loops. Unlike exogenous growth hormone, which can suppress natural production, Sermorelin stimulates the pituitary to release its own stored GH, governed by the regulatory influence of somatostatin.

The GHRH Receptor Signaling Axis

Upon activation by Sermorelin, the GHRH receptors on pituitary somatotrophs initiate a cyclic adenosine monophosphate (cAMP)-dependent pathway. This facilitates the synthesis and pulsatile release of endogenous growth hormone into the circulation.

Key Mechanistic Shifts:

• Endogenous Stimulation: Sermorelin facilitates a more physiological GH release compared to synthetic secretagogues, providing a framework for studying natural endocrine rhythms.
• Somatostatin Interaction: Researchers use Sermorelin to observe how the pituitary overcomes inhibitory signals to maintain hormonal balance.
• IGF-1 Modulation: Activation of this pathway leads to a downstream increase in Insulin-like Growth Factor 1 (IGF-1), the primary mediator of GH's anabolic effects.

Primary Research Applications

1. Neuroendocrine and Pituitary Function Research

Sermorelin is heavily utilized in studies involving secondary growth hormone deficiency. Because it acts directly on the pituitary, it provides a unique framework for investigating whether a lack of GH is caused by hypothalamic failure or pituitary dysfunction.

2. Sarcopenia and Lean Tissue Adaptation

Known in research circles for its "anti-aging" potential, Sermorelin is used to observe how tissues adapt to increased GH levels. Investigators study changes in protein synthesis, nitrogen retention, and the reversal of muscle atrophy in animal models of senescence.

3. Circadian Rhythm and Sleep Research

In sleep science, Sermorelin is investigated for its role in promoting restorative sleep. Research models focusing on the hypothalamus examine how GHRH analogs influence the duration and quality of non-REM sleep cycles.

Form and Analytical Testing

At Dragon Pharma, the commitment to scientific accuracy begins with a rigorous manufacturing process. Sermorelin 5mg is produced under strict laboratory conditions to ensure that the compound remains stable and bioactive.

• Lyophilization for Stability: The compound is supplied in a lyophilized (freeze-dried) form. This process removes moisture while preserving the delicate peptide sequence, ensuring it arrives at your facility in optimal condition.
• Rigorous Analytical Verification: To guarantee a purity level of 99% or higher, every batch undergoes High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm that the chemical signature matches the intended GRF 1-29 profile.

Product Usage Disclaimer: This product is intended for laboratory and in-vitro research use only. It is not approved for human or veterinary application. Must be handled by qualified professionals. Not for drug, food, or cosmetic purposes. Misuse or misbranding is strictly prohibited.

Author:

All information was searched/edited by Dr. S. Edwin, and Dr. E. Croft who holds a doctorate from Case Western Reserve University School of Medicine

Refference:

• https://case.edu/medicine/